Dolutegravir Lamivudine Abacavir
Triumeq is a combination antiretroviral medication used to treat HIV-1 infection in adults and children. It contains three active ingredients that work together to suppress the virus and reduce viral load. Triumeq is typically prescribed for patients who meet specific clinical criteria and have no prior history of hypersensitivity to any of its components.
Triumeq is an HIV-1 treatment combining three antiretroviral agents to suppress viral replication.
Key facts at a glance
- RxNorm
- 1546889
- Generic
- Triumeq
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Triumeq is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. It is used as part of a complete antiretroviral regimen for patients who have been assessed and meet clinical prescribing criteria. HLA-B*5701 testing is required before initiation due to abacavir hypersensitivity risk.
Triumeq contains three active ingredients: dolutegravir (an integrase strand transfer inhibitor) and two nucleoside reverse transcriptase inhibitors (abacavir and lamivudine). Dolutegravir blocks HIV integrase, preventing viral DNA from integrating into host cell DNA. Abacavir and lamivudine inhibit reverse transcriptase, blocking the conversion of viral RNA to DNA.
Triumeq carries a boxed warning for serious hypersensitivity reactions associated with abacavir. Patients must be screened for HLA-B*5701 before starting therapy. It should not be used in patients with hepatitis B co-infection unless appropriate hepatitis B treatment is added. Common side effects may include headache, fatigue, and gastrointestinal symptoms. Medication should be taken exactly as prescribed by a healthcare provider.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy